The race for a COVID-19 vaccine has commanded international focus since the pandemic began, so where do things stand now that autumn is approaching? A number of vaccine candidates, including some from the federal government’s Operation Warp Speed initiative, have begun clinical trials. Experts have not ruled out the possibility of FDA approval in record time and mass distribution by early 2021. But as research proceeds at a breakneck pace and vaccines become a political hot button in the lead up to the November election, scientists must delicately balance speed, efficacy, and safety. What will the first “successful” vaccine look like, and which criteria should be used to make that determination?
On Monday, Sept. 14 at 8:30 a.m., we’ll chat with Dr. Peter Hotez, Dean of the National School of Tropical Medicine at Baylor College of Medicine. Dr. Hotez will discuss his own ongoing COVID-19 vaccine research in partnership with Texas Children’s Hospital, assess the current state of clinical trials nationally, and discuss the controversy around the concept of herd immunity. He’ll also answer your questions live during a moderated Q&A session.
This free public webinar is presented by the Colorado School of Public Health, the Denver Museum of Nature & Science, and the Institute for Science & Policy. The session will also be streamed on Facebook Live.